Related Experiment Videos
[Heart transplantation--status and perspectives]
1Klinik für Thorax-, Herz- und Gefässchirurgie, Medizinische Hochschule Hannover.
Insights
Heart transplantation (HTx) is a viable treatment for end-stage heart failure, with survival rates over 70%. Addressing donor organ shortages and improving rejection/infection management are key challenges for this complex procedure.
Area of Science:
- Cardiology
- Transplant Surgery
Context:
- Heart transplantation (HTx) is an established treatment for terminal cardiac failure.
- The procedure faces challenges including donor organ scarcity and managing post-transplant complications.
Purpose:
- To discuss the current state and challenges of heart transplantation based on 160 cases.
- To highlight areas for improvement in HTx protocols and resource allocation.
Summary:
- Long-term survival rates for HTx exceed 70%, but persistent mortality and morbidity are linked to inadequate rejection and infection control.
- The increasing use of circulatory support devices presents new challenges, potentially mitigated by artificial hearts.
- Donor organ availability remains a critical bottleneck, necessitating broader organ sourcing strategies.
Impact:
- Emphasizes the need for specialized centers to centralize organ transplantations for improved outcomes and resource management.
- Suggests advancements in artificial hearts may alleviate challenges associated with circulatory support.
- Underscores the importance of optimizing immunosuppression and infection prophylaxis to enhance patient survival and quality of life post-HTx.
Abstract:
Transplantation of the heart (HTx) has become a realistic procedure in the treatment of terminal cardiac failure. However, several problems remain and are to be discussed on the basis of our experience in 160 cases of HTx. A dramatic widening of indications for HTx presently is not to be expected while the lack of donor organs is magnified by the growing transplantation frequency. This bottle neck only can be lessened by mobilization of all organ sources. Longterm survival rate in HTx patients seems to stabilize at well over 70%. Persisting mortality and morbidity of HTx are the result of imperfect recognition and treatment of rejection as well as infection. The use of circulatory aids in patients expecting HTx and in those with a failing transplant is of growing importance at the same time posing the problem of high urgency in patients thus instrumented. It is likely that the intermediate-term use of the totally implantable artificial heart will lessen this dilemma. Costs and efforts of cardiac transplantation are considerable. A plea therefore is made for concentration of organ transplantations of all types in special centers.